Search Grant Opportunities

Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional)

Type: Posted • Opportunity: PAR-24-107

Description

The purpose of this notice of funding opportunity (NOFO) is to support applications from small businesses to develop solutions for commercialization that enable regional genomic medicine eConsult Service.

Overview

Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 1/9/24 the National Institutes of Health posted grant opportunity PAR-24-107 for Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional). The grant will be issued under grant program 93.172 Human Genome Research.

Timing

Posted Date
Jan. 9, 2024, 12:00 a.m. EST
Closing Date
May 30, 2024, 12:00 a.m. EDT Due in 97 Days
Last Updated
Jan. 9, 2024, 2:31 p.m. EST
Version
1
Archive Date
July 5, 2024

Eligibility

Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/pa-files/PAR-24-107.html

Documents

Posted documents for PAR-24-107

Potential Applicants and Partners

Awardees that have recently won grants similar to PAR-24-107

Incumbent or Similar Grants

Grants similar to PAR-24-107

Similar Active Opportunities

Open grant opportunities similar to PAR-24-107